Sanofi raises stakes in cancer vaccine race
An exclusive license to a late stage product has enabled Sanofi-aventis to up the stakes in a bid to be the first company to release a dedicated cancer vaccine.
Archives for March 29, 2007
Russian laboratory equipment market
The expansion of a Russian laboratory exhibition highlights the growth in the Russian analytical and laboratory equipment market.
Horiba Jobin Yvon's Activa-M excites for bronze
A new inductively coupled plasma (ICP) optical emission spectrometer (OES) brings the technique into the hands of the non-expert for the first time.
More preclinical data needed for high-risk first-in-man trials
More analysis of a drug's target and mode of action in the preclinic has been called for in the draft guidelines for first-in-man trials published by the European Medicines Agency (EMEA).
Extreme pipetting
Artel is sending three of their employees to the most extreme environments in the US to demonstrate the impact of environmental conditions on pipetted volumes.
Merck insomnia drug put to bed
A next-generation insomnia drug has been put to bed after its developers decided the risk of using the drug outweighed its potential benefit to millions of insomnia sufferers.